Helicobacter pylori is a gram-negative bacterial species that selectively colonizes gastric epithelium and induces chronic inflammation. World Health Organization has classified H. pylori as a class I carcinogen for gastric cancer, and as virtually all infected persons have superficial gastritis. Several clinical trials indicated that probiotic supplementation during anti-Helicobacter pylori treatment may be effective for improving H. pylori eradication rates, minimizing the incidence of therapy related adverse events and alleviating most disease-related clinical symptoms.
Advantages of AHP
●The best adherence ability in the human gastric epithelial cells
●Acid-resistant bacteria
●Effectively inhibit the adherence and invasion of H. pylori
●Effectively inhibit the growth of multidrug-resistant H. pylori strains
●Decrease the levels of H. pylori CagA virulence factor
●Prevent H. pylori infection
●Decrease H. pylori-induced gastric inflammation
●Improve gut microbiota
Product Information:
●Form: capsule, sachet, tablet
●Increase the added-value of the original product : Probiotic
AHP-1 can be added into fermentation products, dietary
supplement, and milk (resh/powder) to enhance the
nutrition values
Targeted users:
●People with H. pylori infection have gastric symptoms
●People with gastric ulcer, duodenal ulcer, and peptic ulcer